» Articles » PMID: 2896800

Electrophoretic Analysis of P-glycoproteins Produced by Mouse J774.2 and Chinese Hamster Ovary Multidrug-resistant Cells

Overview
Specialty Oncology
Date 1988 Jun 1
PMID 2896800
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

P-glycoprotein (P-gp) plays a fundamental role in multidrug resistance. The quantity of P-gp relates to the degree of drug resistance. A comparison was made between P-gps in mouse and hamster cell lines in both Laemmli and modified Fairbanks gel systems. Both proteins are derived from precursors of similar size that undergo differential N-linked glycosylation. The electrophoretic mobility and the amount of P-gp are remarkably dependent on the conditions of analysis. Notably, boiling P-gp before Laemmli gel electrophoresis decreases its mobility by an amount that is equivalent to approximately equal to 15 kDa and results in an apparent diminution in the amount of protein. The latter effect can give a false impression concerning the quantity of P-gp in cells.

Citing Articles

Photoaffinity labeling of the multidrug resistance protein 2 (ABCC2/cMOAT) with a photoreactive analog of LTC(4).

Leimanis M, Karwatsky J, Georges E Int J Biochem Mol Biol. 2011; 2(1):39-46.

PMID: 21968553 PMC: 3180033.


P-glycoprotein structure and evolutionary homologies.

Bosch I, Croop J Cytotechnology. 2008; 27(1-3):1-30.

PMID: 19002778 PMC: 3449573. DOI: 10.1023/A:1008080911522.


Effect of P-glycoprotein on flavopiridol sensitivity.

Boerner S, Tourne M, Kaufmann S, Bible K Br J Cancer. 2001; 84(10):1391-6.

PMID: 11355953 PMC: 2363628. DOI: 10.1054/bjoc.2000.1688.


Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.

Dale I, Tuffley W, Callaghan R, Holmes J, Martin K, LUSCOMBE M Br J Cancer. 1998; 78(7):885-92.

PMID: 9764579 PMC: 2063130. DOI: 10.1038/bjc.1998.597.


Evaluation of 2,6-diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)- hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitro.

Sha E, Sha M, Kaufmann S Invest New Drugs. 1996; 13(4):285-94.

PMID: 8824346 DOI: 10.1007/BF00873134.